A cross-linked hyaluronic acid hydrogel (Healaflow(®)) as a novel vitreous substitute.

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskriftPeer review

33 Citeringar (SciVal)

Sammanfattning

Vitrectomy requires the substitution of the natural vitreous, as well as tamponading of retinal breaks. Clinically available alternatives such as gas and silicone oil have side effects such as inflammation, secondary glaucoma, cataract, and a need for head posturing. In this study, a hydrogel of cross-linked sodium hyaluronic acid (Healaflow(®)) is evaluated for use as a novel vitreous substitute.
Originalspråkengelska
TidskriftGraefe's Archive for Clinical and Experimental Ophthalmology
Tidigt onlinedatum2016 jan. 8
DOI
StatusPublished - 2016

Ämnesklassifikation (UKÄ)

  • Oftalmologi

Fingeravtryck

Utforska forskningsämnen för ”A cross-linked hyaluronic acid hydrogel (Healaflow(®)) as a novel vitreous substitute.”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här